Indications:
Gastroesophageal Reflux Disease (GERD)

-Treatment of reflux esophagitis

-Long-term treatment for prevention of relapse in patients with healed esophagitis

-Symptom control in GERD
Combination with appropriate antibacterial therapy for eradication of Helicobacter pylori; and

-Healing of Helicobacter pylori-associated duodenal ulcers

-Prevention of relapse in Helicobacter pylori-associated peptic ulcers
Patients requiring continuous NSAID therapy

-Treatment of gastric ulcers associated with NSAID (non-steroidal anti-inflammatory drug) therapy

Strength:20mg、40mg

National Drug Approval Number:H20203210、H20203211